Article Text

Download PDFPDF

An evaluation of sotalol, a β-blocking agent, in patients with angina pectoris
  1. P. G. Gooding,
  2. E. Berman


    In a multi-centre study, sotalol was compared with placebo in 146 patients with angina pectoris using a double-blind crossover design. Sotalol had a significant effect in reducing the number of anginal attacks and the number of nitroglycerin tablets used. The medication was safe and produced minimal side effects.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.